Your browser doesn't support javascript.
loading
Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro.
Zekri, Latifa; Ruetalo, Natalia; Christie, Mary; Walker, Carolin; Manz, Timo; Rammensee, Hans-Georg; Salih, Helmut R; Schindler, Michael; Jung, Gundram.
Afiliação
  • Zekri L; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Tübingen, Germany.
  • Ruetalo N; German Cancer Research Center (DKFZ) Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.
  • Christie M; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Walker C; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Manz T; Institute for Medical Virology and Epidemiology, University Hospital Tübingen, Tübingen, Germany.
  • Rammensee HG; School of Life and Environmental Sciences and School of Life of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.
  • Salih HR; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Tübingen, Germany.
  • Schindler M; German Cancer Research Center (DKFZ) Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.
  • Jung G; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Tübingen, Germany.
Front Immunol ; 14: 1112505, 2023.
Article em En | MEDLINE | ID: mdl-36969164
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article